APA
PRDS

American Portfolios Advisors’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

American Portfolios Advisors’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.85K Hold
1,000
– – ﹤0.01% 3150
2022
Q2 		$3.07K Hold
1,000
– – ﹤0.01% 3003
2022
Q1 		$7.22K Hold
1,000
– – ﹤0.01% 2816
2021
Q4 		$16.4K Buy
+1,000
New +$11.6K ﹤0.01% 2407

Other funds holding PRDS

FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

American Portfolios Advisors's PRDS Position: Q3 2022 in Review

American Portfolios Advisors held its Pardes Biosciences, Inc. Common Stock (PRDS) position steady in Q3 2022 at 1,000 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3150.

American Portfolios Advisors first reported a position in PRDS in Q4 2021 and has held it in 4 quarters since. The position peaked at $16.4K in Q4 2021. 68 funds tracked by Wall St. Rank hold PRDS as of Q3 2022.

  • American Portfolios Advisors held 1,000 shares of Pardes Biosciences, Inc. Common Stock worth $1.85K as of Q3 2022.
  • American Portfolios Advisors left its Pardes Biosciences, Inc. Common Stock share count unchanged in Q3 2022.
  • Pardes Biosciences, Inc. Common Stock made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3150 holding.
  • American Portfolios Advisors first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2021 and has held it in 4 quarters since.
  • American Portfolios Advisors's Pardes Biosciences, Inc. Common Stock position peaked at $16.4K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.